136-150 of 893
Joshua Sharfstein, MD
Stephanie Desmon
Maximilian Konig, MD
Chetan Bettegowda, MD, PhD
Finding the Best “Cocktail” of Treatments for COVID-19
Public Health On CallFinding the Best “Cocktail” of Treatments for COVID-19
Joshua Sharfstein, MD
Derek C. Angus, MD, MPH, FRCP
Unlocking More Secrets of COVID-19: Seasonality, Flu Comparisons, & What We’re Learning in the Lab
Public Health On CallUnlocking More Secrets of COVID-19: Seasonality, Flu Comparisons, & What We’re Learning in the Lab
Joshua Sharfstein, MD
Stephanie Desmon
Andrew Stanley Pekosz, PhD
Everything You Need to Know About Antibody Testing for COVID-19
Public Health On CallEverything You Need to Know About Antibody Testing for COVID-19
Joshua Sharfstein, MD
Gigi Kwik Gronvall, PhD
Dr. Jennifer Nuzzo Answers Even More of Your COVID-19 Questions
Public Health On CallDr. Jennifer Nuzzo Answers Even More of Your COVID-19 Questions
Joshua Sharfstein, MD
Jennifer Nuzzo, MD
Joshua Sharfstein, MD
Stephanie Desmon
Annette C. Anderson, PhD
- advertisement
What’s Next with COVID-19: Considerations for Reopening Gyms, Bars, & Other Non-Essential Businesses
Public Health On CallWhat’s Next with COVID-19: Considerations for Reopening Gyms, Bars, & Other Non-Essential Businesses
Joshua Sharfstein, MD
Caitlin Rivers, PhD, MPH
Not Just a Pandemic: Why COVID-19 Is a Health Equity Issue
COVID-19: On The FrontlinesNot Just a Pandemic: Why COVID-19 Is a Health Equity Issue
Mario R. Nacinovich, Jr., MSc
Renata Schiavo, PhD, MA
Protecting the Vulnerable from COVID-19: A Street Physician’s Perspective
COVID-19: On The FrontlinesProtecting the Vulnerable from COVID-19: A Street Physician’s Perspective
Shira Johnson, MD
James Withers, MD
How Radiation Oncologists Are Adapting Patient Care Amid COVID-19
COVID-19: On The FrontlinesHow Radiation Oncologists Are Adapting Patient Care Amid COVID-19
Mario R. Nacinovich, Jr., MSc
Anthony Dragun, MD
Overcoming Arising Complications in Lung Cancer Care Due to COVID-19
COVID-19: On The FrontlinesOvercoming Arising Complications in Lung Cancer Care Due to COVID-19
Mario R. Nacinovich, Jr., MSc
Jonathan Riess, MD, MS
Joshua Sharfstein, MD
Stephanie Desmon
Julie Messersmith
Denis Wirtz
- advertisement
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
The Drug ReportThe DEA’s Adjustment to Schedule II Rules Amid COVID-19
Linda Bernstein, Pharm.D.
FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
The Drug ReportFDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
Linda Bernstein, Pharm.D.
Linda Bernstein, Pharm.D.